Evaluation of Performances, Clinical Benefits and Safety of the 'Audiocap' Connected Hearing Rehabilitation Device for Improving Audibility in Hearing-impaired People in the Context of CE Marking - AUDIOCAP-2
A legfontosabb adatok
- Ki végzi
- Archean Technologies
- Hol
- Franciaország4 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 100 fő, tervezett
- Kezdés
- 2025. szept. 10.
- Várható befejezés
- 2027. szept.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Audiocap connected hearing aid
- Placebo
- A regiszteradat frissítve
- 2025. november 26.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with hearing loss who will use a hearing aid for the first time. It compares the Audiocap connected hearing aid with a placebo setting.
- Életkor
- Over 18 years.
- Nem
- All sexes can join.
- A betegség stádiuma
- Mild to moderate hearing loss (20dB to 50dB average at 500, 1000, 2000 and 4000 Hz) in the better ear, or other set hearing test results. These include speech hearing threshold in quiet above 30dB, clearly worse speech understanding in noise (more than 3dB from normal), or high-pitch hearing loss above 30dB from 2000 Hz.
- Korábbi kezelés
- People must never have had a hearing aid before. People with ear implants cannot join.
A részvétel fő kizáró okai
- Disabling ringing in the ears (THI>56).
- People who could have a cochlear implant.
- Ear infections with pus, ear discharge, or a malformed ear or ear canal.
- Sudden hearing loss in the past 3 months, fast-worsening deafness, hearing loss in one ear only, or fluctuating hearing.
- Severe psychiatric disorder, or allergy to the device materials.
A regiszter feltételei, szó szerint
Mind a 22 feltétel megnézéseKevesebb
Ki vehet részt
- Subjects presenting one or more of the following criteria: a.Subject with mild to moderate hearing loss (20dB to 50dB average at 500, 1000, 2000, and 4000 Hz) in the better ear according to WHO standards, / b. Subject with a speech reception threshold (SRT) in quiet exceeding 30dB, corresponding to the minimum speech level required to achieve 50% recognition in silence (HAS eligibility criteria for hearing aid reimbursement), / c. Subject with significant degradation of speech intelligibility in noise, defined as a speech-to-noise ratio (SNR) deviation greater than 3dB compared to normative reference values (HAS eligibility criteria for hearing aid reimbursement), / d.Subject with high-frequency hearing loss greater than 30dB from 2000 Hz onwards, associated with a speech reception threshold exceeding 30dB in quiet and/or a significantly degraded speech intelligibility in noise (HAS eligibility criteria for hearing aid reimbursement)
- Subjects eligible for first hearing aid
- Subjects over 18 years of age. French-speaking subjects
- Subjects affiliated with a social security scheme. 6. Subjects who are not subject to another medical option, without external pathology and excluding implants
- Subjects who have signed an informed consent. 8. Subjects available for the study
Ki nem vehet részt
- Subjects eligible for a cochlear implant
- Subject with severe psychiatric disorder
- Subjects with sudden onset of hearing loss within the past 3 months, rapid progressive deafness, unilateral hearing loss or other acute ear disease
- Subjects who are allergic to materials of the device
- Subject deprived of his/her liberty by a judicial or administrative decision
- Subject admitted to a health or social care establishment
- Subject not able to give consent
- Adults under guardianship or trusteeship
- Subjects with disabling tinnitus that are not suitable for adaptation (THI>56)
- Subjects not able to participate in the study according to the investigator
- Subjects with acute and chronic suppurative otitis media, congenital ear atresia, or any type of ear discharge
- Subjects with congenital atresia of external ear or deformity of any part of the ear canal
- Subjects with deafness that is unstable and with a degree of hearing loss often fluctuating
- Subjects with persistent headaches, dizziness, earaches, or other symptoms that are not suitable for adaptation
- Subjects with effusion (secretions/ discharge) in the ear and/or frequent purulence (pus)
- Subjects with central deafness (central nervous system) or non-organic deafness
- Subjects with acute otitis extrema and tympanitis
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is the evaluation of performances, clinical benefits and safety of the 'Audiocap' connected hearing rehabilitation device for improving audibility in hearing-impaired people.
A teljes eredeti leírásKevesebb
The main question it aims to answer is to demonstrate, after one month's use of the Audiocap connected hearing aid, that the audiological gain for the patient is better than with a placebo hearing aid.
Placebo hearing aid is a Audiocap connected hearing aid with a 'NONE' setting (flat frequency response for the patient (equivalent to not wearing hearing aid).
Participants will be first-time hearing aid users, eligible for hearing aid fitting, and adults according to French legislation (18 years and older).
A vizsgálat 2 csoportja
- Interventional ArmMár használt kezelés, összehasonlításként
First period of one month: Audiocap connected hearing aid in a standard interplay path.
Kezelés: Audiocap connected hearing aid
- Control ArmPlacebo, összehasonlításként
First period of one month: Audiocap connected hearing aid with a 'NONE' setting (flat frequency response for the patient (equivalent to not wearing hearing aid) in a standard interplay path.
Kezelés: Placebo
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Evaluation of Performances, Clinical Benefits and Safety of the 'Audiocap' Connected Hearing Rehabilitation Device for Improving Audibility in Hearing-impaired People in the Context of CE Marking
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2025. november 26.